News Focus
News Focus
icon url

labner

05/10/14 2:54 PM

#27386 RE: jessellivermore #27385

[quote2) Cut expenses to a minimum the directors and management should be on bread and water. ][/quote]

putting all the other factors aside, I see no point in a company having less than a 500 m market cap and a price share of 1.50 and only having one drug on the market, with eight board of directors and lucrative sign on bonuses. Plus the management can spin it any way they want but they are not on the shareholders side and have not felt any financial pain, If their options are expired, they have been reissued and when the 2011 option plan did not have enough shares, they create more shares ie restricted shares and shares issued outside of the plan for sign on bonuses. In their proxy statement last week the compensation committee claims they where in the 50 percentile of like 15 comparative companies (listed in the proxy) There is no comparison, research any of those companies and compare their pay to the stock price and the pipeline. Amarin needs to start caring about the shareholders, many of whom lost thousands and thousands of dollars to their incompetents and misleading statements.
icon url

HDGabor

05/10/14 3:47 PM

#27390 RE: jessellivermore #27385

You have right regarding BioC and me however it's not a comparison. According to all accounting standard, you have to show the net (real) revenue, so in every 10-Q the revenue is after discount to wsalers, coupon, etc. (btw: BioC check your calculation ie.: 7/4/2014 12018 $4,136,496.00 should be $2,019,024.00)

1.) Yes, agree and u were conservative. My current guess for script is 8,364 (end of Q2), 14,009 (Q3 w KOWA), 20,084 (Q4 w KOWA).

2.) Yes. I guess (hope) that the current level (11,7 R&D, 20,6 SGA) could be decreased to 8-8,5 R&D, 16-17 SGA), so additional 6,8-8,3M decrease on quaterly basis.

3.) If mission 1 & 2 completed they do not need a partner, they will have enough cash to see the interim result by end of 2016 (data vill be available Q12016).
icon url

BioChica

05/10/14 8:49 PM

#27404 RE: jessellivermore #27385

I am so anxious to see how the Kowa reps perform! I hope they blow are current sales force out of the water! I believe this will be an incentive for them to work harder. Though I know they are probably doing good job under the current circumstances.

Another area where I think J.Z. made a bad choice. Bad IDEA for a small company to build a sales force from scratch! Payroll/Insurance/Trainng/Support Personnel.
icon url

mrmainstreet

05/11/14 1:57 AM

#27412 RE: jessellivermore #27385

JL, I spoke with Joe Bruno and he said there is a provision in the loan where the company can choose to pay a percent of revenue instead of the scheduled loan payments. I would suggest others call IR and confirm this in case I heard it wrong or misunderstood. This was a couple months ago and Joe was pretty positive about this aspect of the loan agreement as it works in Amarin's favor.